Il y a eu 50 transactions d'initiés récentes enregistrées pour Amneal Pharmaceuticals, Inc. (AMRX), dont 17 achats et 33 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $5.01M.
Les initiés notables ayant une activité récente comprennent Boyer Andrew S, Konidaris Tasos, Patel Chintu. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — AMRX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-04 |
Boyer Andrew S |
Executive Vice President |
Exercice d'Options (Vente) |
38,195 |
- |
- |
76,389 |
| 2026-03-04 |
Konidaris Tasos |
Executive Vice President & CFO |
Exercice d'Options (Vente) |
49,982 |
- |
- |
87,963 |
| 2026-03-04 |
Patel Chintu |
Co-CEO |
Exercice d'Options (Vente) |
92,593 |
- |
- |
185,185 |
| 2026-03-04 |
Shah Nikita |
Executive Vice President |
Exercice d'Options (Vente) |
35,880 |
- |
- |
71,760 |
| 2026-03-04 |
Patel Chirag K. |
President & Co-CEO |
Exercice d'Options (Vente) |
92,593 |
- |
- |
185,185 |
| 2026-03-04 |
Daly Jason B. |
EVP, Chief Legal Officer |
Exercice d'Options (Vente) |
35,880 |
- |
- |
71,760 |
| 2026-03-03 |
Boyer Andrew S |
Executive Vice President |
Exercice d'Options (Vente) |
39,252 |
- |
- |
- |
| 2026-03-03 |
Konidaris Tasos |
Executive Vice President & CFO |
Exercice d'Options (Vente) |
458,716 |
- |
- |
- |
| 2026-03-03 |
Patel Chintu |
Co-CEO |
Exercice d'Options (Vente) |
733,944 |
- |
- |
- |
| 2026-03-03 |
Shah Nikita |
Executive Vice President |
Exercice d'Options (Vente) |
36,232 |
- |
- |
- |
| 2026-03-03 |
Patel Chirag K. |
President & Co-CEO |
Exercice d'Options (Vente) |
733,944 |
- |
- |
- |
| 2026-03-03 |
Daly Jason B. |
EVP, Chief Legal Officer |
Exercice d'Options (Vente) |
305,810 |
- |
- |
- |
| 2026-03-02 |
Boyer Andrew S |
Executive Vice President |
Attribution de RSU |
65,359 |
- |
- |
65,359 |
| 2026-03-02 |
Konidaris Tasos |
Executive Vice President & CFO |
Attribution de RSU |
72,622 |
- |
- |
72,622 |
| 2026-03-02 |
Patel Chintu |
Co-CEO |
Attribution de RSU |
190,632 |
- |
- |
190,632 |
| 2026-03-02 |
Shah Nikita |
Executive Vice President |
Attribution de RSU |
65,359 |
- |
- |
65,359 |
| 2026-03-02 |
Patel Chirag K. |
President & Co-CEO |
Attribution de RSU |
190,632 |
- |
- |
190,632 |
| 2026-03-02 |
Daly Jason B. |
EVP, Chief Legal Officer |
Attribution de RSU |
65,359 |
- |
- |
65,359 |
| 2026-03-02 |
Patel Chintu |
Co-CEO |
Attribution de RSU |
544,663 |
- |
- |
544,663 |
| 2026-03-02 |
Patel Chirag K. |
President & Co-CEO |
Attribution de RSU |
544,663 |
- |
- |
544,663 |
| 2025-11-17 |
Nark Ted C |
Director |
Vente Informative |
50,000 |
$11.72 |
$586K |
291,029 |
| 2025-11-12 |
Shah Nikita |
Executive Vice President |
Exercice d'Options (Vente) |
95,525 |
$2.75 |
$262.69K |
- |
| 2025-08-27 |
Kiely John |
Director |
Vente Informative |
32,000 |
$9.23 |
$295.36K |
225,433 |
| 2025-08-25 |
Shah Nikita |
Executive Vice President |
Vente Informative |
6,340 |
$9.50 |
$60.23K |
146,403 |
| 2025-08-22 |
Shah Nikita |
Executive Vice President |
Vente Informative |
114,492 |
$9.66 |
$1.11M |
152,743 |
| 2025-06-16 |
Patel Gautam |
Director |
Vente Informative |
94,906 |
$8.02 |
$761.15K |
1,609,144 |
| 2025-06-10 |
Patel Gautam |
Director |
Vente Informative |
56,426 |
$8.02 |
$452.54K |
1,704,050 |
| 2025-05-16 |
Shah Nikita |
Executive Vice President |
Vente Informative |
49,140 |
$7.58 |
$372.48K |
388,929 |
| 2025-05-12 |
Kiely John |
Director |
Vente Informative |
50,000 |
$7.59 |
$379.5K |
257,433 |
| 2025-05-06 |
Meister Paul M |
Director |
Attribution de RSU |
48,747 |
- |
- |
48,747 |
| 2025-05-06 |
Buchi J Kevin |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Nark Ted C |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Yanai Shlomo |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Patel Gautam |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Alva Emily Peterson |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Kiely John |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
George Jeffrey P. |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-06 |
Autor Deborah M. |
Director |
Attribution de RSU |
34,819 |
- |
- |
34,819 |
| 2025-05-05 |
Patel Gautam |
Director |
Vente Informative |
4,900 |
$8.00 |
$39.2K |
1,720,218 |
| 2025-05-05 |
Meister Paul M |
Director |
Exercice d'Options (Vente) |
56,361 |
- |
- |
- |
| 2025-05-05 |
Buchi J Kevin |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Nark Ted C |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Yanai Shlomo |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Patel Gautam |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Alva Emily Peterson |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Kiely John |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
George Jeffrey P. |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-05 |
Autor Deborah M. |
Director |
Exercice d'Options (Vente) |
40,258 |
- |
- |
- |
| 2025-05-02 |
Patel Gautam |
Director |
Vente Informative |
3,768 |
$8.00 |
$30.14K |
1,725,118 |
| 2025-04-01 |
Patel Gautam |
Director |
Vente Informative |
80,000 |
$8.30 |
$664K |
1,728,886 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
